Genomma Lab Internacional S.A.B. de C.V (LABB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (LABB) has a cash flow conversion efficiency ratio of -0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (MX$-229.17 Million ≈ $-13.19 Million USD) by net assets (MX$11.72 Billion ≈ $674.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Genomma Lab Internacional S.A.B. de C.V (LABB) balance sheet quality index to measure how much of total assets are equity-financed.
Genomma Lab Internacional S.A.B. de C.V - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Genomma Lab Internacional S.A.B. de C.V to evaluate the quality of earnings relative to operating cash generation.
Genomma Lab Internacional S.A.B. de C.V Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genomma Lab Internacional S.A.B. de C.V ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dilip Buildcon Limited
NSE:DBL
|
-0.441x |
|
Close Brothers Group plc
F:CS3
|
-0.084x |
|
Cromwell Property Group
AU:CMW
|
0.023x |
|
Xiamen Guang Pu Electronics Co Ltd
SHE:300632
|
0.003x |
|
Dongfeng Electronic Technology Co Ltd
SHG:600081
|
0.063x |
|
Hunan Jiudian Pharmaceutical Co Ltd
SHE:300705
|
0.068x |
|
Grupo Posadas S.A.B. de C.V
MX:POSADASA
|
0.097x |
|
Zhejiang Tony Electronic Co Ltd
SHG:603595
|
0.050x |
Annual Cash Flow Conversion Efficiency for Genomma Lab Internacional S.A.B. de C.V (2005–2025)
The table below shows the annual cash flow conversion efficiency of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see LABB market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | MX$11.11 Billion ≈ $639.47 Million |
MX$2.05 Billion ≈ $118.24 Million |
0.185x | -29.37% |
| 2024-12-31 | MX$11.59 Billion ≈ $666.93 Million |
MX$3.03 Billion ≈ $174.59 Million |
0.262x | +39.15% |
| 2023-12-31 | MX$9.38 Billion ≈ $539.98 Million |
MX$1.77 Billion ≈ $101.58 Million |
0.188x | -7.05% |
| 2022-12-31 | MX$10.15 Billion ≈ $584.28 Million |
MX$2.05 Billion ≈ $118.25 Million |
0.202x | +38.83% |
| 2021-12-31 | MX$10.07 Billion ≈ $579.66 Million |
MX$1.47 Billion ≈ $84.50 Million |
0.146x | -18.08% |
| 2020-12-31 | MX$9.63 Billion ≈ $554.45 Million |
MX$1.71 Billion ≈ $98.67 Million |
0.178x | +40.93% |
| 2019-12-31 | MX$7.97 Billion ≈ $458.91 Million |
MX$1.01 Billion ≈ $57.95 Million |
0.126x | -39.97% |
| 2018-12-31 | MX$7.43 Billion ≈ $427.47 Million |
MX$1.56 Billion ≈ $89.92 Million |
0.210x | +6.49% |
| 2017-12-31 | MX$7.05 Billion ≈ $405.65 Million |
MX$1.39 Billion ≈ $80.13 Million |
0.198x | -13.06% |
| 2016-12-31 | MX$6.79 Billion ≈ $390.93 Million |
MX$1.54 Billion ≈ $88.83 Million |
0.227x | +76.83% |
| 2015-12-31 | MX$9.25 Billion ≈ $532.26 Million |
MX$1.19 Billion ≈ $68.39 Million |
0.128x | +29.94% |
| 2014-12-31 | MX$10.50 Billion ≈ $604.46 Million |
MX$1.04 Billion ≈ $59.77 Million |
0.099x | -53.30% |
| 2013-12-31 | MX$8.84 Billion ≈ $508.48 Million |
MX$1.87 Billion ≈ $107.66 Million |
0.212x | +1222.65% |
| 2011-12-31 | MX$5.57 Billion ≈ $320.72 Million |
MX$89.21 Million ≈ $5.13 Million |
0.016x | -92.25% |
| 2010-12-31 | MX$4.11 Billion ≈ $236.63 Million |
MX$849.67 Million ≈ $48.90 Million |
0.207x | +63.53% |
| 2009-12-31 | MX$3.05 Billion ≈ $175.57 Million |
MX$385.52 Million ≈ $22.19 Million |
0.126x | +27.65% |
| 2008-12-31 | MX$2.31 Billion ≈ $133.06 Million |
MX$228.89 Million ≈ $13.17 Million |
0.099x | -43.72% |
| 2007-12-31 | MX$587.44 Million ≈ $33.81 Million |
MX$103.33 Million ≈ $5.95 Million |
0.176x | +59.27% |
| 2005-12-31 | MX$164.93 Million ≈ $9.49 Million |
MX$18.21 Million ≈ $1.05 Million |
0.110x | -- |
About Genomma Lab Internacional S.A.B. de C.V
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products t… Read more